Funding for this research was provided by:
Universidade do Porto
Article History
Accepted: 3 December 2023
First Online: 20 December 2023
Declarations
:
: Open access funding provided by FCT|FCCN (b-on).
: Diana Bernado has no conflicts of interest to declare in relation to this work. Diamant Thaçi has received honoraria for participation on advisory boards, as a speaker, and for consultancy services from AbbVie, Almirall, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celltrion, Eli Lilly, Galapagos, Galderma, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron, Sanofi Genzyme, and UCB Pharma; and has received research grants from LEO Pharma and Novartis. Tiago Torres has received consultancy and/or speaker’s honoraria from, and/or participated in clinical trials sponsored by, AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz and UCB.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: DB, DT, and TT conceived the idea for this article, performed the literature search and data analysis, and drafted and critically revised the work.